An epidemiological registry study to evaluate clinical practice treatment in patients with Bipolar Disorder - REED
Study identifier:VD-NS-1101
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An epidemiological registry study to evaluate clinical practice treatment in patients with Bipolar Disorder treated with quetiapine XR and/or quetiapine IR
Medical condition
Bipolar Disorder
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
16000
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Nov 2011
Primary Completion Date: 01 Apr 2012
Study Completion Date: 01 Apr 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Aug 2014 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Andreas Carlborg
Department of Clinical Neuroscience, Karolinska Institutet 171 76 Stockholm
